4.3 Article

Comparison of MOG and AQP4 antibody seroprevalence in Korean adults with inflammatory demyelinating CNS diseases

期刊

MULTIPLE SCLEROSIS JOURNAL
卷 27, 期 6, 页码 964-967

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458520948213

关键词

Aquaporin-4; myelin oligodendrocyte glycoprotein; prevalence; adult

资金

  1. Korean Neurological Association [KNA-19-SK-12]
  2. Advanced Research Center Program of the National Research Foundation [NRF-2018R1A5A2023127]
  3. Korean Centers for Disease Control and Prevention [2020ER690100]
  4. Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare [HC17C0078]

向作者/读者索取更多资源

In Korean adults with inflammatory demyelinating diseases (IDDs) of the central nervous system (CNS), the seroprevalence of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies was about five times lower than that of anti-aquaporin-4 (AQP4) antibodies.
We aimed to compare seroprevalence of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-aquaporin-4 (AQP4) antibodies in Korean adults with inflammatory demyelinating diseases (IDDs) of the central nervous system (CNS), based on a multicenter nationwide database. Sera were analyzed using a live cell-based assay for MOG and AQP4 antibodies. Of 586 Korean adults with IDDs of the CNS, 36 (6.1%) and 185 (31.6%) tested positive for MOG and AQP4 antibodies, respectively. No participant showed double positivity. Seroprevalence of MOG antibodies was about five times lower than that of AQP4 antibodies in a large cohort of Korean adults with IDDs of the CNS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据